Penumbra Inc

Penumbra Inc

PEN

Get informed when a big investor buys or sells

+ Follow
Market Cap$12.52B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Penumbra IncPenumbra Inc73.1-12%8.70.1
$356.33

Target Price by Analysts

11.1% upsidePenumbra Target Price DetailsTarget Price
$81.64

Current Fair Value

74.5% downside

Overvalued by 74.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$12.52 Billion
Enterprise Value$12.49 Billion
Dividend Yield$- (-)
Earnings per Share$4.57
Beta0.74
Outstanding Shares39,275,424

Return

Return on Equity11.61%ROE
Return on Assets9.01%
Return on Invested Capital11.58%

Valuation & Multiples

P/E Ratio73.09P/E Ratio
PEG-431.8PEG
Price to Sales8.67Price to Sales
Price to Book Ratio8.67Price to Book Ratio
Enterprise Value to Revenue8.59
Enterprise Value to EBIT63.96
Enterprise Value to Net Income73
Total Debt to Enterprise0.02
Debt to Equity0.15Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 6, 2026
EPS Estimate
$1.06
Average shareholder expectation
Revenue Estimate
$370.47 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 4, 2026
EPS Estimate
$1.18
Average shareholder expectation
Revenue Estimate
$389.40 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio1.6945 140.33%
Total Calls191,800 19.58%
Total Puts325,000 595.93%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %86.95% 7.22%
Total Invested$11.11B 2.90%
Investors Holding494 48.00%

ESG Score

No data

About Penumbra Inc

CEO: Adam Elsesser

Relevant Senate Committees

Finance

This committee controls taxation, trade, and entitlement spending, crucially influencing corporate valuations through tax policy and directly impacting medical device companies through Medicare pricing and reimbursement structures.

Appropriations

This committee allocates discretionary federal spending. Its subcommittees determine precise funding for various programs, including healthcare initiatives and research that directly impact government purchases of medical devices and related R&D.

Health, Education, Labor, and Pensions

This committee directly regulates the FDA, which is the primary body for medical device approvals, and the NIH, which funds medical research. This oversight profoundly impacts Penumbra's core business, product development, and market access.

Judiciary

This committee oversees antitrust laws and intellectual property, both critical for the medical device industry's innovation, market competition, and protection of patented technologies crucial to Penumbra.

Veterans' Affairs

This committee directly oversees the Department of Veterans Affairs, whose funding decisions significantly impact government healthcare contractors and medical device manufacturers like Penumbra, as the VA is a major healthcare provider and purchaser.